← Horseradish

Glucosinolates, Antimicrobial Properties, and Anti-Inflammatory Effects

How horseradish's unique glucosinolates deliver broad-spectrum antimicrobial activity, reduce inflammation, and support respiratory and urinary health

Horseradish (Armoracia rusticana) is far more than a condiment. It belongs to the same plant family as broccoli and mustard, and shares their signature health-promoting chemistry: glucosinolates that break down into potent isothiocyanates when the root is grated or chewed [2]. The primary compound, allyl isothiocyanate (AITC), is a broad-spectrum antimicrobial that has been used in traditional European medicine for centuries to treat respiratory infections, sinusitis, and urinary tract infections [4][5]. Lab and clinical evidence now supports these traditional uses. Horseradish root extracts also reduce production of key inflammatory signals including TNF-α and IL-6 through inhibition of the NF-κB pathway [1]. For people who enjoy its pungent bite, regular horseradish is an easy way to add meaningful antimicrobial and anti-inflammatory compounds to their diet.

How Horseradish Becomes Medicinal

The health-active compounds in horseradish don't exist preformed in the root — they're created on demand through an enzymatic reaction. Horseradish contains large amounts of the glucosinolate sinigrin, which makes up roughly 83% of the total glucosinolate content [2]. Stored separately within the plant cells is the enzyme myrosinase. When the root is grated, chewed, or otherwise damaged, the two come into contact and react rapidly: myrosinase cleaves sinigrin into allyl isothiocyanate (AITC), glucose, and a sulfate group.

AITC is the primary bioactive compound responsible for horseradish's characteristic sharp heat and most of its health effects. It is highly bioavailable — nearly 90% of ingested AITC is absorbed through the gut [3]. It then moves through the body and is excreted primarily through the kidneys, concentrating in urinary tissue at levels 14–79 times higher than plasma — a fact that helps explain its traditional effectiveness for urinary tract infections [3].

Practical note: Heat destroys myrosinase. Cooked horseradish loses most of its glucosinolate-converting activity. Fresh-grated horseradish or commercially prepared horseradish (not heat-processed) delivers the most active compounds.

Broad-Spectrum Antimicrobial Activity

AITC exerts antimicrobial activity against both gram-positive and gram-negative bacteria through multiple mechanisms. It disrupts bacterial membrane integrity, interferes with enzyme function by reacting with thiol groups, and inhibits the metabolic pathways bacteria need to generate energy and replicate [4]. This multi-target action makes it difficult for bacteria to develop resistance, an important property as antibiotic resistance grows globally.

Research confirms that the antibacterial activity of horseradish root extracts is attributable exclusively to the isothiocyanate compounds — other phytochemicals in the root do not contribute meaningfully to antimicrobial effects [4]. This means the medicinal potency depends directly on how much AITC is generated, which in turn depends on fresh preparation and intact myrosinase activity.

The antimicrobial activity extends to respiratory pathogens, which is why horseradish has been used across European cultures for chest infections and sinus congestion. AITC volatilizes at body temperature, so when consumed it releases antimicrobial vapor into the respiratory passages — a mechanism that aligns well with its traditional use as a decongestant and expectorant.

Anti-Inflammatory Effects

Beyond its antimicrobial properties, horseradish root exerts measurable anti-inflammatory effects. Research using macrophage cell models (immune cells central to the inflammatory response) found that horseradish root extracts reduced production of:

  • Nitric oxide — an inflammatory signaling molecule
  • TNF-α (tumor necrosis factor-alpha) — a cytokine that drives systemic inflammation
  • IL-6 (interleukin-6) — another pro-inflammatory cytokine

These effects are mediated through inhibition of NF-κB (nuclear factor kappa B), a master transcription factor that controls the expression of hundreds of inflammatory genes [1]. The extracts also suppressed the inflammatory enzymes iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2), and increased expression of heme oxygenase-1, a cytoprotective enzyme with potent antioxidant properties [1].

Respiratory and Urinary Tract Support

The two most traditional uses for horseradish — respiratory infections and urinary tract infections — both have biological explanations grounded in AITC's pharmacokinetics.

Respiratory Health

AITC reaches respiratory tissues directly when inhaled as vapor and indirectly through the bloodstream. It reduces bacterial burden in airways while also acting as an expectorant — helping thin and clear mucus. A clinical trial of horseradish combined with nasturtium (another isothiocyanate-rich plant) for acute bronchitis found statistically significant improvements in symptoms compared to placebo within just three days [5]. The 10-day trial enrolled 384 patients and showed sustained benefits in coughing, mucus production, and chest pain. The isothiocyanates from both plants were identified as the mechanism responsible for these effects.

Urinary Tract Health

AITC's concentration in urinary tissues — up to 79 times higher than plasma levels — makes it particularly well-suited for urinary tract infections [3]. High urinary concentrations maintain antimicrobial activity throughout the urinary tract. Traditional use of horseradish for UTIs aligns with this pharmacological profile, though controlled clinical trials specifically for UTIs are limited.

Practical Use

  • Fresh grated is the most potent form — grate immediately before eating
  • Prepared horseradish in jars (refrigerated, with vinegar) retains some activity if not heat-processed
  • Avoid horseradish sauce and similar products that have been heated or heavily diluted
  • A teaspoon or two of fresh or prepared horseradish several times per week is a reasonable culinary amount
  • At the onset of a respiratory infection, increasing horseradish intake (along with nasturtium if available) is consistent with both traditional use and the clinical trial evidence [5]
  • Horseradish can irritate the digestive tract in large amounts — moderation is appropriate

See our garlic page for related antimicrobial food research, and our sulforaphane page for the related glucosinolate mechanism in broccoli.

Evidence Review

Glucosinolate Chemistry and Content

Li and Kushad (2004) in the Journal of Agricultural and Food Chemistry (PMID 15537302) conducted a systematic analysis of glucosinolate content across 27 horseradish root accessions and 9 leaf samples. They identified eight distinct glucosinolates in horseradish tissues. In mature roots, sinigrin dominated at approximately 83% of total glucosinolates, with gluconasturtiin contributing ~11% and glucobrassicin ~1%. Total glucosinolate concentrations varied substantially across accessions, ranging from 2 to 296 µmol/g dry weight — a range that reflects meaningful differences in medicinal potency depending on variety and growing conditions. Myrosinase activity ranged from 1.2 to 57.1 units per gram dry weight. In leaf tissue, myrosinase activity showed significant positive correlations with both total glucosinolate content (r = 0.78) and sinigrin specifically (r = 0.80), though roots showed no such correlation. The authors noted that tissue damage triggered rapid glucosinolate breakdown via swift myrosinase activation, confirming that cutting or grating is the critical step for generating bioactive isothiocyanates.

Anti-Inflammatory Activity in Macrophages

Marzocco et al. (2015) in Food & Function (PMID 26411988) tested three varieties of horseradish root extract on RAW 264.7 macrophages stimulated with bacterial lipopolysaccharide (LPS) — a standard model of inflammatory activation. All three extracts reduced production of nitric oxide, TNF-α, and IL-6 in a dose-dependent manner. At the molecular level, the extracts suppressed expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), two enzymes central to inflammatory responses. The mechanism of action involved inhibition of NF-κB p65 nuclear translocation — preventing the master inflammatory transcription factor from activating its target genes. The extracts also reduced intracellular reactive oxygen species (ROS) and upregulated heme oxygenase-1 (HO-1), a protective enzyme with antioxidant and anti-inflammatory properties. The authors attributed these effects to glucosinolates and their isothiocyanate breakdown products, consistent with the known bioactivity of AITC and related compounds.

Allyl Isothiocyanate Bioavailability and Cancer Prevention

Zhang (2010) in Molecular Nutrition & Food Research (PMID 19960458) reviewed the evidence for AITC as a chemopreventive phytochemical with particular focus on bladder cancer. Approximately 90% of orally administered AITC is absorbed through the gastrointestinal tract and metabolized through the mercapturic acid pathway before urinary excretion. Urinary concentrations of AITC equivalents exceed plasma levels by approximately tenfold. Most significantly, bladder tissue accumulates AITC at concentrations 14–79 times higher than other organs — a remarkable pharmacokinetic property that positions AITC as particularly relevant for urinary tract health. In animal models, AITC inhibited cancer cell growth, induced apoptosis, and suppressed tumor growth at multiple stages of carcinogenesis. The review also noted AITC's broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria. At dietary exposure levels, AITC exhibits low cytotoxicity and genotoxicity, suggesting a favorable safety profile for regular consumption.

Phytochemical and Functional Analysis

Negro et al. (2022) in Fitoterapia (PMID 35988845) performed detailed phytochemical characterization of both fermented and non-fermented horseradish root extracts, focusing on compounds relevant to the plant's traditional use for respiratory and urinary tract infections. Using LC-MS and activity-guided fractionation, the researchers demonstrated that antibacterial activity was exclusively attributable to isothiocyanate compounds — specifically AITC and related breakdown products from sinigrin. Other phytochemicals present in the root, including kaempferol glycosides, spirobrassinin, and amino acid derivatives (several newly identified in this study), did not contribute meaningfully to antimicrobial activity. The researchers also found that fermentation enhanced enzymatic isothiocyanate production, suggesting fermented horseradish preparations may have increased antimicrobial potency. This mechanistic clarity — isothiocyanates are the active agents, not the whole extract — has important implications for product standardization and dosing.

Clinical Trial for Acute Bronchitis

Albrecht, Stefenelli, and Stange (2023) in Phytomedicine (PMID 37167822) conducted a randomized, placebo-controlled trial of a fixed herbal combination containing horseradish root (Armoracia rusticana) and nasturtium herb (Tropaeolum majus) for acute bronchitis. The trial enrolled 384 adult patients (195 treatment, 189 placebo) over a 10-day treatment period. The treatment group showed statistically significant improvement in bronchitis symptoms within three days, with continued benefit through day 10. Measured outcomes included reductions in coughing frequency, mucus production, and chest pain. The authors identified the isothiocyanates produced by both plants — allyl isothiocyanate from horseradish sinigrin and benzyl isothiocyanate from nasturtium gluconasturtiin — as the active antimicrobial and anti-inflammatory agents responsible for the clinical effects. They also described horseradish's mechanistic contributions: three distinct isothiocyanates with antibacterial, anti-inflammatory, and immunomodulatory functions. This is one of the few controlled clinical trials demonstrating efficacy of horseradish-containing preparations in a relevant human disease setting, providing reasonable clinical support for traditional respiratory uses.

Summary of Evidence

The evidence for horseradish spans mechanistic biochemistry, in vitro antimicrobial studies, and at least one well-designed clinical trial. The glucosinolate-to-isothiocyanate conversion pathway is thoroughly characterized. AITC's pharmacokinetics — high bioavailability, urinary concentration, and respiratory distribution — provide a clear mechanistic basis for traditional uses in UTIs and respiratory infections. Anti-inflammatory effects via NF-κB inhibition are demonstrated in macrophage models. The clinical trial for acute bronchitis provides human-level evidence supporting the combination of horseradish and nasturtium for respiratory infections. The evidence base is strongest for antimicrobial and anti-inflammatory applications; direct randomized trials for UTI prevention in humans remain limited but are mechanistically supported. Overall, horseradish has a well-grounded scientific rationale as a functional food with genuine health utility beyond its culinary role.

References

  1. Anti-inflammatory activity of horseradish (Armoracia rusticana) root extracts in LPS-stimulated macrophagesMarzocco S, Calabrone L, Adesso S, Larocca M, Franceschelli S, Autore G, Martelli G, Rossano R. Food & Function, 2015. PubMed 26411988 →
  2. Correlation of glucosinolate content to myrosinase activity in horseradish (Armoracia rusticana)Li X, Kushad MM. Journal of Agricultural and Food Chemistry, 2004. PubMed 15537302 →
  3. Allyl isothiocyanate as a cancer chemopreventive phytochemicalZhang Y. Molecular Nutrition & Food Research, 2010. PubMed 19960458 →
  4. Phytochemical and functional analysis of horseradish (Armoracia rusticana) fermented and non-fermented root extractsNegro EJ, Sendker J, Stark T, Lipowicz B, Hensel A. Fitoterapia, 2022. PubMed 35988845 →
  5. A combination of Tropaeolum majus herb and Armoracia rusticana root for the treatment of acute bronchitisAlbrecht U, Stefenelli U, Stange R. Phytomedicine, 2023. PubMed 37167822 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.